Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.165ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
V.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.149ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.413ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.107ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.469ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.80 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.8 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
AY.128 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.220ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.438ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.257ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.5.6 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.440ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.23.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.104 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.198ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
XAFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
P.1.17.1 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.15 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.82ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used